Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia

N Engl J Med. 2016 Aug 4;375(5):494-6. doi: 10.1056/NEJMc1600337.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Child, Preschool
  • Humans
  • Infant
  • Janus Kinase 2 / antagonists & inhibitors*
  • Male
  • Nitriles
  • Polycythemia / congenital*
  • Polycythemia / drug therapy
  • Pyrazoles / therapeutic use*
  • Pyrimidines

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib
  • JAK2 protein, human
  • Janus Kinase 2

Supplementary concepts

  • Erythrocytosis, Familial, 2